|
ATF7IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.319800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.970490E-02 |
| Normal-vs-Stage2 |
1.294110E-02 |
| Normal-vs-Stage3 |
2.552700E-04 |
| Normal-vs-Stage4 |
9.996000E-04 |
| Stage1-vs-Stage2 |
3.263400E-01 |
| Stage1-vs-Stage3 |
3.211700E-02 |
| Stage1-vs-Stage4 |
8.402000E-02 |
| Stage2-vs-Stage3 |
6.693000E-01 |
| Stage2-vs-Stage4 |
7.493000E-01 |
| Stage3-vs-Stage4 |
9.462800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.964400E-03 |
| Normal-vs-AfricanAmerican |
3.991000E-01 |
| Normal-vs-Asian |
1.597800E-02 |
| Caucasian-vs-AfricanAmerican |
3.346400E-01 |
| Caucasian-vs-Asian |
8.073000E-01 |
| AfricanAmerican-vs-Asian |
3.264600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.318800E-03 |
| Normal-vs-Female |
3.557900E-03 |
| Male-vs-Female |
3.962800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.010020E-01 |
| Normal-vs-Age(41-60Yrs) |
2.582600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.581300E-04 |
| Normal-vs-Age(81-100Yrs) |
8.279400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.666500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.311950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.232380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.906800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.189800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.601800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.143780E-02 |
| Classical-VS-Follicular |
3.502300E-03 |
| Classical-VS-Other |
7.927800E-02 |
| Classical-VS-Normal |
7.032000E-02 |
| Tall-VS-Follicular |
9.864400E-01 |
| Tall-VS-Other |
3.397600E-01 |
| Tall-VS-Normal |
7.616000E-04 |
| Follicular-VS-Other |
4.954600E-01 |
| Follicular-VS-Normal |
2.223600E-04 |
| Other-VS-Normal |
6.204500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.402430E-03 |
| Normal-vs-N1 |
2.459100E-03 |
| N0-vs-N1 |
5.989600E-01 |
|
|
